ARTICLE | Company News
FDA approves BioDelivery's Bunavail
June 10, 2014 12:09 AM UTC
BioDelivery Sciences International Inc. (NASDAQ:BDSI) said FDA approved Bunavail buprenorphine naloxone as maintenance treatment for opioid dependence. The company said it plans to launch the product ...